Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

The Rise and Fall of RNAi

Andrew Pollack in the New York Times concluded that pharmaceutical companies' interest in RNA interference is waning as other opportunities have higher priorities. The delivery of RNAi still remains a major challenge that is being addressed by a few academics and companies. S. Pelech notes that it took about two decades before the relatively simple process of how to produce monoclonal antibodies ultimately resulted in government-approved drugs for treatment of cancer and other diseases. The application of RNAi to mitigate the actions of specific micro-RNA might ultimately prove to be the best therapeutic use of RNA intereference. Read More...